Friday 6 November 2026 Export TFX’s income statement to Excel — free account

Teleflex Incorporated

TFX Healthcare Medical Instruments & Supplies

Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.

Revenue: +28.9%
EPS: −17.3%
Free cash flow: +220.1%
Total debt: +47.7%

Quarter to June 2026, against a year earlier

Dividend growth 25 yrs

152.16 2.29 +1.53%

Follow TFX

Alert me

Market cap: $6.5B
P/E: 0.0×
Fwd P/E: 37.4×
Dividend yield: 0.89%
F-score: 5/9
Altman Z: 2.04
Beneish M: −2.21
Dividend safety: 20/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Teleflex Incorporated (TFX) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Teleflex Incorporated (TFX) trades at a price to free cash flow of 125×. Over the past ten years it has ranged from 0.0× (December 2025) to 3,905× (January 2026); the current reading is higher than 98% of that period. That is above the Medical Instruments & Supplies industry median of 23.5× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/TFX/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Teleflex Incorporated price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/TFX/metrics/price-to-free-cash-flow">Teleflex Incorporated (TFX) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	3,766×	9,452.57%
FY2024	39.4×	(46.48%)
FY2023	73.7×	65.73%
FY2022	44.4×	67.95%
FY2021	26.5×	(52.08%)
FY2020	55.2×	10.73%
FY2019	49.9×	49.62%
FY2018	33.3×	3.34%
FY2017	32.3×	67.53%
FY2016	19.3×	(14.70%)

Period	Price to free cash flow	Change
Jun 2026	104×	250.63%
Mar 2026	29.6×	(99.21%)
Dec 2025	3,766×	—
Sep 2025	0.0×	—
42 more quarters	Free account

Against its own ten years

Low 0.0× High 3,905×

Ten-year median 33.1×

Current reading's percentile 98

Company	Price to free cash flow
PLSE Pulse Biosciences, Inc compare	n/m
MMED MiniMed Group, Inc. compare	n/m
NVST Envista Holdings Corporation compare	16.4×
ICUI ICU Medical, Inc. compare	21.2×
AVTR Avantor, Inc. compare	23.3×
MMSI Merit Medical Systems, Inc. compare	23.6×
ATR AptarGroup, Inc. compare	31.0×
BLCO Bausch + Lomb Corporation compare	31.4×
TFX Teleflex Incorporated	125×
Medical Instruments & Supplies industry median	23.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Teleflex Incorporated (TFX) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on TFX

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on TFX

Stockrow Weekly